Weight Loss

Adults living with obesity, or overweight with a weight-related health condition, may qualify for a clinical research study evaluating an

Adults 18 years and older with overweight or obesity and without type 2 diabetes may qualify for a study evaluating

Adults who are overweight or obese and currently using semaglutide (Ozempic®/Wegovy®) or tirzepatide (Mounjaro®/Zepbound®) may qualify for a research study

We are currently enrolling a weight loss study evaluating the safety, tolerability and effectiveness of a GLP-1 and GIP medication. If